研究方向：抗肿瘤金属化合物耐药机制

在读期间发表论文：

1. Jiang M, Zhang ZL, Li WJ, Man XY, Sun HB, Liang H*, Yang F*. Developing a copper(II) agent based on His-146 and His-242 residues of human serum albumin nanoparticles: integration to overcome cisplatin resistance and inhibit the metastasis of nonsmall cell lung cancer. Journal of Medicinal Chemistry, 2022, 65: 9447−9458.

2. Jiang M, Chu Y, Yang TF, Li WJ, Zhang ZL, Sun HB, Liang H*, Yang F*. Developing a novel indium(III) agent based on liposomes to overcome cisplatin-induced resistance in breast cancer by multitargeting the tumor microenvironment components. Journal of Medicinal Chemistry, 2021, 64: 14587−14602.

3. Jiang M, Yang TF, Chu Y, Zhang ZL, Sun HB, Liang H*, Yang F*. Design of a novel Pt( II ) complex to reverse cisplatin-induced resistance in lung cancer via a multi-mechanism. Dalton Transactions, 2022, 51: 5257−5270.

4. Jiang M, Li SH, Wu JM, Li WJ, Wen X, Liang H, Yang F*. Designing biotin-human serum albumin nanoparticles to enhance the targeting ability of binuclear ruthenium(III) compound. Journal of Inorganic Biochemistry, 2021, 215: 111318.

学习经历：

2019/09-2022/12，广西师范大学化学与药学学院(博士)

2013/09-2016/06，广西师范大学生命科学学院(硕士)，本课题组硕士

2009/09-2013/06，九江学院生命科学学院(学士)

邮箱：747227336@qq.com